Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Alpha-1 proteinase inhibitor

EU orphan designation number: EU/3/06/350   
Active ingredient: Alpha-1 proteinase inhibitor
Indication: Treatment of emphysema secondary to congenital alpha-1 antitrypsin deficiency
Sponsor: Octapharma (IP) Limited
The Zenith Building, 26 Spring Gardens, Manchester M2 1AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Centralised Orphan - Designation EMEA/OD/092/05 (2006)551 of 16/02/2006
26/03/2009 Other procedure